Zantac Cancer Litigation Moving Forward
Zantac cancer lawsuits are in the early stages of multidistrict litigation (MDL) during which cases filed around the country in federal and state court are organized
Thursday, April 8, 2021 - Multidistrict litigation saves the court millions of dollars by consolidating certain administrative procedures and also prevents the repetitive testimony of expert witnesses in mass tort lawsuits. MDL is more efficient in cases of personal injury involving complicated medical science. "District Judge Robin Rosenberg has appointed a team of 26 lawyers to lead Zantac lawsuits after conducting a two-day virtual leadership interview involving more than 60 lawyers," according to South Florida Caribean News. At present, plaintiffs may rely on scientific studies conducted by Memorial Sloan Kettering Cancer Center, online prescription drug testing pharmacy Valisure, and one from the University of Alabama at Birmingham that all point to ranitidine interacting with nitrates in the stomach to form elevated levels of N-Nitrosodimethylamine (NDMA), a deadly carcinogen. Wikipedia describes it as, "N-Nitrosodimethylamine, also known as dimethylnitrosamine, is an organic compound with the formula (CH₃)₂NNO. It is one of the simplest members of a large class of N-nitrosamines. It is a volatile yellow oil. NDMA has attracted wide attention as being highly hepatotoxic and a known carcinogen in lab animals." If you were a regular Zantac user and have received a cancer diagnosis you should speak with a Zantac Cancer Lawyer to explain your rights to hold the negligent manufacturers of the drug accountable.
Plaintiffs that have filed Zantac lawsuits suffer from stomach, bladder, colon, or other gastrointestinal cancer. Most started taking Zantac as directed by its manufacturer Sanofi between 2000 and 2010 and have continued until the drug was recalled by the Food and Drug Administration (FDA) on April 1, 2020. More than 15 million Americans were taking Zantac every day at that time. Zantac cancer litigation could grow to become one of the largest mass tort cases of all time. Zantac users took the ant heartburn and acid reflux medicine up to three times per day. The plaintiffs claim that Sanofi knew or had a responsibility to know that ranitidine was inherently unstable and could break down to form dangerously high levels of NDMA when it interacted with nitrites in the stomach. Nitrites are a common preservative found in processed spicy meat, ironically the same food that caused a person to reach for an antacid in the first place. Zantac cancer plaintiff's positions are bolstered by the current Department of Justice (DOJ) investigation into whether Sanofi executives lied to government regulators about their knowledge of ranitidine and NDMA formation. Most Zantac plaintiffs have suffered painful personal injury resulting in the loss of the enjoyment of life. Younger plaintiffs have monetary damages such as loss of income, and all have incurred medical expenses. Some have diminished earnings capacity also. Reports have come in that US military veterans used Zantac anti-heartburn drugs frequently. Members of the military or veterans are among those injured by the medicine. There is still time to file a Zantac Cancer lawsuit by contacting a Zantac Cancer lawyer and filing a claim.
More Recent Heartburn MedicineLawsuit News:
- Time Remains To File A Zantac Cancer Claim | 7/28/2021
- Both Sides Have Made Progress In Zantac Multidistrict Litigation | 7/27/2021
- When Did Sanofi Know Ranitidine Become Carcinogenic | 7/23/2021
- NDMA Is Present In Hot Dogs, Bacon And Other Cured Meats In High Amounts | 7/22/2021
- The Longer Ranitidine Remained On Store Shelves, The More Carcinogenic It May Have Become | 7/16/2021
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.